in an experimental mouse model of PCOS [42]
A large cardiovascular outcomes trial found that higher proportions of tirzepatide recipients reported vomiting, diarrhea, and nausea compared to those taking a selective GLP-1RA
Abstract Glucagon-like peptide-1 medicines are being prescribed to growing numbers of patients worldwide, for type 2 diabetes, obesity and associated comorbidities, including cardiovascular disease, peripheral artery disease and obstructive sleep apnea, and are revolutionizing public health strategies for these conditions
Further ion channel research using recently developed, relevant models (such as organoids) could provide critical molecular and functional insights into gynecological pathologies and implantation-related infertility problems
By boosting NAD+ levels, we're essentially giving these guardians more "fuel" to do their important work